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ORIGINAL ARTICLE
The global incidence of cancer has risen dramati-
cally in recent decades.1 In Taiwan, cancer deaths
have also increased sharply, and cancer has be-
come the leading cause of death since 1982.2 In
2007 alone, 40,306 (28.9% of total deaths) people
in Taiwan died of cancer.2 Although many new
medical technologies and anticancer medica-
tions have been developed, most cancer patients
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Background/Purpose: As the number of terminal cancer patients increases, several care models have been
adopted to provide better care quality and reduce medical expenditure. This study compared inpatient
medical expenditure and family satisfaction in a hospice ward (HW) and general ward (GW) for terminal
cancer patients in Taiwan.
Methods: We enrolled terminal cancer patients who were admitted and died during the same admission
period in a tertiary care hospital in Taiwan from January 2003 to December 2005. These patients were 
allocated into three groups: inpatient care in HW alone; inpatient care in GW alone; and inpatient care in
mixed group (initially in GW, then transferred to HW). Inpatient medical expenditure and family satisfac-
tion were compared between the three groups.
Results: A total of 1942 patients were recruited and allocated into HW (n = 292), GW (n = 1511) and mixed
(n = 139) groups. The average medical expenditure per person or per inpatient day was lower in the HW
than the GW or mixed group. Subjects who had ever been admitted to the intensive care unit or received
cardiopulmonary resuscitation in the GW or mixed groups required more expenditure on medical care than
that in the HW group. Daily medical expenditure in the HW group also was much lower than that in the
GW and mixed groups, based on length of stay and cancer type. The family satisfaction score was significantly
higher in the mixed and/or HW group than the GW group.
Conclusion: For terminal cancer patients, hospice care can improve family satisfaction while reducing
medical expenditure in Taiwan. [J Formos Med Assoc 2009;108(10):794–802]
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are incurable, and clinical signs and symptoms
worsen in the terminal stages.3 Although survival
prediction in early stages of cancer is difficult, 
accurate predictions are possible in later stages.4
Palliative care can alleviate more than 10 symp-
toms from which terminal patients suffer.3,5,6 In
1967, Cicely Saunders established modern hos-
pice palliative medicine in the United Kingdom,
which provided holistic care for terminal pa-
tients. The goals of hospice palliative care are 
to improve the quality of life and offer death with
dignity for terminal patients and their families.
Many studies have demonstrated that hospice
palliative care is one of the best care models for
terminal patients.5,6 In Taiwan, hospice palliative
care was introduced in 1990 and the use of this
care model has increased rapidly.7 For example,
Miceli and Mylod reported that terminal patients
who received hospice care have greater family
satisfaction than those who received usual care.8
Pyenson et al showed that terminal patients who
receive hospice care have a longer time until death
than those who receive non-hospice care.9
Medical expenditure for terminal patients dur-
ing the end-of-life period is vast.10 Barnato et al
determined that 30% of medical expenditure is
spent by 5% of beneficiaries who die within a
year.11 Other researchers have shown that termi-
nal patients incur greater expenditure on medical
care and have longer inpatient stays before death
compared to patients in stable condition.12,13
Spector and Mor reported that medical expendi-
ture increases markedly near the time of death in
terminal patients.13 Hospice palliative care has
demonstrated reduced medical expenditure in
terminally ill patients compared with that of usual
care.7,9,14–16 For example, Pyenson et al reported
that mean and median Medicare expenditure is
lower for patients enrolled in hospice than in
non-hospice care.9 The lower medical expenditure
is not associated with shorter survival time, but
appears to be related to a longer mean time until
death.9 A study conducted by Lo in Taiwan showed
that hospice care incurs less medical expenditure
than usual care in terminal patients.7 The rate of
hospice utilization during the last year of life has
increased rapidly from 5.5% to 15.4% between
2000 and 2004 in Taiwan. These terminal cancer
patients were enrolled into hospice care close to
death (median time till death ranged from 14 to
47 days).17
An important question to ask is whether fam-
ilies of end-of-life patients are satisfied with this
emerging method of care, despite the associated
reduction in medical expenditure. Few studies
have analyzed medical expenditure and family
satisfaction simultaneously when comparing hos-
pice and general care. In this study, we assessed
medical expenditure and family satisfaction with
different care models for terminal cancer patients
in a tertiary medical center in Taiwan, which pro-
vided acute and hospice care.
Subjects and Methods
Participants and characterization
Terminal cancer patients who were admitted to a
tertiary medical center located in central Taiwan,
from January 2003 to December 2005, and who
died during this hospitalization period at the
same center were included. These subjects were
allocated into three groups: (1) general ward
(GW) group, who were admitted to a GW and re-
ceived general care until death; (2) hospice ward
(HW) group, who were admitted to an HW at
the outset and received hospice palliative care
until death; (3) mixed ward (mixed) group, who
were admitted to a GW to begin with and were
transferred to an HW in the same hospitalization
period, and died in the HW. Death coding and
diagnosis of cancer for all subjects were per-
formed at the same medical center. There were
1511, 292 and 139 subjects in the GW, HW and
mixed groups, respectively. Ethical approval was
obtained from the Institutional Review Board of
China Medical University Hospital.
Medical expenditure analyses
Actual medical expenditure was obtained from
the same medical center. Expenditure was di-
vided into 16 subgroups according to the national
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insurance of Taiwan, which included fees for 
diagnosis, laboratory services, X-rays, ther apeu-
tic procedures, rehabilitation, special materials,
psychiatric treatment, injection services, drugs,
dispensing services, wards, tube feeding, surgery,
anesthesia, hemodialysis, and blood/plasma analy-
sis. For comparison, we regrouped these 16 fees
into six domains: (1) diagnosis fees; (2) labora-
tory/X-ray fees; (3) therapeutic fees (therapeutic
procedures, rehabilitation, special materials, psy-
chiatric treatment, and injection services); (4)
drug fees (drugs and dispensing services); (5)
ward fees (wards and tube feeding); and (6) oth-
ers (surgery, hemodialysis, and blood/plasma
analysis). All medical expenditure is presented in
US dollars.
Questionnaires for family satisfaction
Few measurement scales have been developed
for determining the satisfaction of family care-
givers of terminal cancer patients. We could not
find a family satisfaction questionnaire that had
been translated and that was appropriate to
Chinese culture. Therefore, a group of researchers
in the fields of hospice palliative medicine, nurs-
ing, and health behavior reviewed the relevant
literature and compiled 40 questions that as-
sessed family satisfaction. We designed the ques-
tionnaire from two major fields, one from three
domains: physiological, psychosocial, and spiri-
tual aspects; the other from knowledge, attitude,
and skill. Also, we added the equipment of the
ward and overall domain into the original ques-
tionnaire. Five experts, including a medical doc-
tor, social worker, senior nurse, project manager,
and chaplain in the field of hospice palliative
medicine were asked to comment twice on the
content of initial pool items and rate the clarity,
concreteness, centrality and importance of each
item using a 5-point rating scale (1 = not impor-
tant, 5 = very important). The content validity
index (CVI) of each item was calculated based on
the experts’ ratings, and items were considered
adequate if agreement was ≥ 80% between experts.
A similar CVI has been used in many previous
studies.18
Based on the results of the content validation,
30 items were retained from the initial item pool
using a 5-point scale: 1 (strongly dissatisfied); 
2 (dissatisfied); 3 (neither satisfied nor dissatis-
fied); 4 (satisfied); and 5 (strongly satisfied). The
final composition of the questionnaire was as
follows: physiological (6 items); psychosocial (8
items); and spiritual (8 items). Another classifica-
tion method was as follows: knowledge (8 items);
attitude (6 items); and skill (8 items). The equip-
ment and overall domains had three and five
items, respectively. The rating scores were sum-
mated by subscales. The higher the score on a
subscale, the better the rating of family satisfac-
tion. A total of 1942 families were invited to fill
out the questionnaires, and 332 returned com-
pleted questionnaires. The overall response rate
was 17.1%. The response rate among the GW,
mixed and HW groups was 219 (14.5%), 31
(22.3%) and 82 (28.1%), respectively. Reasons
for non-response to our questionnaire included:
refusal (n = 279, 14.4%); incorrect contact infor-
mation (wrong telephone number and/or ad-
dress; n = 489, 25.2%); no answer to attempted
telephone calls during three different periods
(morning, afternoon and night; n = 483, 24.9%);
families lost the questionnaire and were sent an-
other but failed to reply within 3 months (n = 332,
17.1%); and emotional disturbance (grief-related
or otherwise; n = 27, 1.4%).
Statistical analysis
Descriptive statistics were used to characterize
the demographic, medical expenditure, and fam-
ily satisfaction data. The data are presented as
means and standard deviation unless otherwise
indicated. The χ2 test was used to test significant
differences for categorical data among the three
care groups. Student’s t test and analysis of vari-
ance were used to test significant differences for
continuous data in contrasting groups. Post hoc
comparisons between groups were done using
Scheffé’s test. All statistical tests were two-sided
at the 0.05 significance level. These statistical
analyses were performed using SPSS version 13
(SPSS Inc., Chicago, IL, USA).
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Results
A total of 1942 patients were recruited and allo-
cated into the GW (n = 1511, 991 men), mixed
(n = 139, 80 men), and HW (n = 292, 173 men)
groups. The mean age was 61.0, 60.5 and 61.6
years, and the length of stay (from admission
until death) was 17.4, 25.2 and 10.1 days in the
GW, mixed and HW groups, respectively. Liver
cancer (19.5%), lung cancer (17.5%), oropha-
ryngeal cancer (10.2%), hematological malig-
nancy (8.3%), and colorectal cancer (7.7%) were
the top five cancer types among these groups. The
total average expenditure for each inpatient day
was US$284, US$135 and US$102, and the aver-
age total expenditure per person was US$4602,
US$3496 and US$1092 in the GW, mixed and
HW groups, respectively (Table 1). The average
medical expenditure per person and per inpa-
tient day was lowest in the HW group compared
with the mixed and GW groups, and a similar re-
lationship was found for almost all expenditure
subgroups (Table 1).
The mixed and GW groups were divided into
subgroups that identified whether or not they
were admitted to the intensive care unit (ICU).
None of the subjects in the HW group were ad-
mitted to the ICU. The GW group was divided
into two subgroups depending on whether or
not they received cardiopulmonary resuscitation
(CPR). None of the subjects in the mixed and
HW groups received CPR. We found that subjects
in the GW-ICU(+) subgroup had the highest av-
erage daily medical expenditure. The HW group
had the lowest average daily medical expendi-
ture, even when compared with the GW-ICU(–)
and mixed-ICU(–) subgroups. The average daily
medical expenditure was US$509 in the GW-
ICU(+), US$232 in the GW-ICU(–), US$156 in
the mixed-ICU(+) and US$134 in the mixed-
ICU(–) subgroups, and US$102 in the HW
group. Total medical expenditure for each inpa-
tient day was US$647 in the GW-CPR(+) and
US$261 in the GW-CPR(–) subgroups, and
US$135 in the mixed and US$102 in the HW
groups. Subjects in the HW group still had lower
daily average medical expenditure than in the
other subgroups.
Previous studies have found that medical ex-
penditure increases markedly near the time of
death in terminal patients. Therefore, we analyzed
average daily medical expenditure according to
Table 1. Basic data and average medical expenditure per person or per inpatient day among groups*†
GW group (n = 1511) Mixed group (n = 139) HW group (n = 292) p
Male 991 (65.6) 80 (57.6) 173 (59.2) 0.030
Age (yr) 61.0 ± 16.3 60.5 ± 14.9 61.6 ± 14.8 0.757
Length of stay (d) 17.4 ± 14.8 25.2 ± 15.6 10.1 ± 10.2 < 0.001
Average expenditure per
person/average expenditure
per day (US$)
Diagnosis fees 210 ± 182/13 ± 5 247 ± 146/10 ± 1 93 ± 93/9 ± 17 < 0.001/< 0.001
Laboratory/X-ray fees 591 ± 853/45 ± 331 445 ± 544/17 ± 15 60 ± 83/6 ± 8 < 0.001/0.083
Therapeutic fees 745 ± 939/50 ± 56 429 ± 421/17 ± 11 129 ± 165/13 ± 9 < 0.001/< 0.001
Drug fees 1501 ± 2876/81 ± 114 1202 ± 1438/45 ± 34 302 ± 734/31 ± 120 < 0.001/< 0.001
Ward fees 1084 ± 1269/63 ± 51 923 ± 608/36 ± 12 336 ± 383/29 ± 6 < 0.001/< 0.001
Others 557 ± 1261/40 ± 137 256 ± 558/9 ± 17 27 ± 87/3 ± 9 < 0.001/< 0.001
Grand total 4602 ± 5997/284 ± 465 3496 ± 2819/135 ± 55 1092 ± 1401/102 ± 122 < 0.001/< 0.001
*Data presented as n (%) or mean ± standard deviation; †analysis of variance was used for comparing mean values of continuous variables between
groups. GW = general ward; HW = hospice ward.
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the length of stay (Table 2). We found that the
HW group had the lowest average daily medical
expenditure for each length of stay.
Table 3 shows average daily medical expendi-
ture according to cancer type. The HW group had
lower mean daily total expenditure than in the
other groups; however, no further between-group
differences were found for specific diagnoses
such as brain cancer, gastric cancer, intestinal can-
cer, colorectal and intestinal cancer, hematologi-
cal malignancy, renal cancer, prostate cancer, and
cancer of unknown origin.
Table 4 presents family satisfaction across the
groups in different domains. We found that sub-
jects who had ever received hospice palliative
care (mixed and HW groups) had higher family
satisfaction than subjects in the GW group. The
overall score (30 items) of family satisfaction
was 62.9%, 89.1% and 90.7% in the GW, mixed
and HW groups, respectively. The mixed and HW
groups had a higher mean satisfaction score than
the GW group in all domains. There were no sta-
tistically significant differences between scores
for the mixed and HW groups within each domain,
or for the grand total family satisfaction score.
Discussion
The results of this study demonstrate that pa-
tients who rely solely on hospice palliative care
incur substantially less expenditure than do GW
patients or those who transition from the GW to
hospice care. The marked differences in medical
expenditure between HW and GW care extended
to most cancer types. In addition to the fiscal dif-
ferences between these end-of-life treatment op-
tions, the family of patients who had received
any form of hospice palliative care reported
greater satisfaction than that of patients in GWs.
Hospice care saved US$182 in medical ex-
penditure per inpatient day by comparison with
Table 2. Average daily medical expenditure among groups based on length of stay
Length of GW group Mixed group HW group 
p* p† p‡ p§
stay (d) (n = 1511) (n = 139) (n = 292)
< 3 376 ± 995 0 75 ± 29 0.006 – < 0.001 –
(n = 225) (n = 0) (n = 83)
≥ 3 268 ± 281 135 ± 55 113 ± 141 < 0.001 0.435 < 0.001 < 0.001
(n = 1286) (n = 139) (n = 209)
< 7 333 ± 772 118 ± 31 98 ± 168 0.001 0.936 < 0.001 0.373
(n = 484) (n = 8) (n = 146)
≥ 7 260 ± 189 136 ± 56 106 ± 37 < 0.001 0.143 < 0.001 < 0.001
(n = 1027) (n = 131) (n = 146)
< 14 304 ± 613 118 ± 40 100 ± 139 < 0.001 0.856 < 0.001 0.049
(n = 802) (n = 34) (n = 219)
≥ 14 260 ± 185 140 ± 58 108 ± 41 < 0.001 0.204 < 0.001 < 0.001
(n = 709) (n = 105) (n = 73)
< 28 288 ± 507 134 ± 57 101 ± 126 < 0.001 0.544 < 0.001 0.002
(n = 1220) (n = 91) (n = 271)
≥ 28 264 ± 206 136 ± 51 113 ± 53 < 0.001 0.638 < 0.001 < 0.001
(n = 291) (n = 48) (n = 21)
*Analysis of variance was used for comparing mean values of continuous variables between groups; †post hoc comparison between
HW and mixed groups using the least significant difference (LSD) test; ‡post hoc comparison between HW and GW groups using the
LSD test; §post hoc comparison between mixed and GW groups using the LSD test. GW = general ward; HW = hospice ward.
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general care. Compared with medical expendi-
ture in the HW group, terminal cancer patients in
the GW-ICU(+) subgroup incurred an average
extra US$407 per inpatient day. Each patient in
the HW group saved US$545 per inpatient day
compared with those in the GW-CPR(+) sub-
group. Previous studies have reported that med-
ical expenditure increases more rapidly as death
approaches, and that hospice care can save more
than general care.7,14 We found that the largest
savings in average daily medical expenditure be-
tween general and hospice care were in subjects
who died within 3 days of admission. The med-
ical expenditure saved for each inpatient day was
US$301 (Table 2). In agreement with previous
studies, our results demonstrate that the average
daily medical expenditure increases as death 
approaches (Table 2). In the GW group, patients
who died within 3 days of admission incurred
additional costs of US$112 per day compared
with those who died at 28 or more days after ad-
mission. However, patients in the HW group
who died within 3 days of admission had the
lowest average daily medical expenditure. One
possible reason for this difference is that, in con-
trast to the GW group, obvious signs of dying 
in the HW patients precluded aggressive treatment
to sustain life (such as CPR). Rather, medical 
care was focused more aggressively on increasing
quality of life and dignity of death for patients
and families during this period. Family satisfac-
tion was greater in the HW and mixed group
than the GW group, therefore, it is reasonable 
to propose that hospice palliative care is a more
appropriate care model than usual care during
this period.
Table 3. Average daily medical expenditure among groups based on different cancer types
Cancer type
GW group Mixed group HW group 
p* p† p‡ p§
(n = 1511) (n = 139) (n = 292)
Oropharyngeal cancer 233 ± 136 147 ± 22 103 ± 32 < 0.001 0.385 < 0.001 0.067
(n = 154) (n = 7) (n = 38)
Esophageal/gastric cancer 275 ± 319 150 ± 57 91 ± 32 0.001 0.475 0.001 0.086
(n = 132) (n = 16) (n = 34)
Liver cancer 281 ± 466 128 ± 52 128 ± 300 0.026 0.999 0.027 0.074
(n = 306) (n = 28) (n = 45)
Lung cancer 218 ± 155 111 ± 28 96 ± 33 < 0.001 0.715 < 0.001 0.004
(n = 280) (n = 16) (n = 43)
Pancreatic/gallbladder 212 ± 135 128 ± 38 107 ± 40 < 0.001 0.586 0.001 0.009
cancer (n = 80) (n = 16) (n = 19)
Colorectal and intestinal 385 ± 1375 144 ± 66 93 ± 33 0.313 0.858 0.176 0.327
cancer (n = 104) (n = 25) (n = 35)
Hematological cancer (leukemia/ 435 ± 348 228 ± 146 153 ± 121 0.228 0.791 0.162 0.303
multiple myeloma) (n = 156) (n = 3) (n = 3)
Urinary bladder/renal/ 247 ± 145 117 ± 36 93 ± 30 < 0.001 0.699 < 0.001 0.019
prostate cancer (n = 46) (n = 6) (n = 13)
Breast cancer 265 ± 271 90 ± 25 88 ± 35 0.004 0.987 0.002 0.059
(n = 69) (n = 7) (n = 22)
Ovarian/cervical/ 268 ± 164 146 ± 35 93 ± 32 < 0.001 0.202 < 0.001 0.002
endometrial cancer (n = 39) (n = 13) (n = 25)
Other cancers 306 ± 237 173 ± 130 109 ± 43 0.005 0.708 0.002 0.410
(n = 145) (n = 2) (n = 15)
*Analysis of variance was used for comparing mean values of continuous variables between groups; †post hoc comparison between HW and mixed groups
using the least significant difference (LSD) test; ‡post hoc comparison between HW and GW groups using the LSD test; §post hoc comparison between
mixed and GW groups using the LSD test. GW = general ward; HW = hospice ward.
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Previous studies have shown that hospice care
provides high levels of family satisfaction.19–21
For example, Miceli and Mylod reported greater
family satisfaction under hospice care than
under the care of a personal physician.8 In agree-
ment with that study, we also found that patients
who had ever received hospice care (either mixed
or HW group) had greater family satisfaction
than patients who received general care. In the
HW model in Taiwan and in most other coun-
tries, care is provided by a well-trained team that
includes hospice palliative specialists, nurses, 
social workers, chaplains, volunteers, and other
workers. Most terminal cancer patients were
transferred to a hospice ward by oncologists or
anticancer physicians whose primary responsibility
was to cure cancer. Our results demonstrated that
continuity of care from the original anticancer
team was not the major factor that influences
family satisfaction. Moreover, the well-trained
hospice team was a key point of satisfaction for
family and patients.
That family satisfaction did not differ be-
tween the mixed and HW groups, yet still was
greater than that in the GW group, suggests that
full or partial reliance on hospice palliative care
is beneficial compared with GW care. However,
hospice palliative care was likely not the only
factor that explained the differences in family
satisfaction between the mixed and HW groups.
For example, aggressiveness of care might differ
between groups, especially if a do-not-resuscitate
order exists. The understood goals of medical
therapy are to prolong life, increase quality of
life, and respect dignity of patients. For the treat-
ment of terminal cancer patients, the goals lean
more toward the latter two in hospice palliative
care than in usual care, but are targeted no less
aggressively. The potential effects of these and
other confounding variables could explain some
Table 4. Analysis of family satisfaction according to different domains
Groups (n) and GW group* Mixed group* HW group* 
p† p‡ p§ p
response rate (%) (n = 219; 14.5%) (n = 31; 22.3%) (n = 82; 28.1%)
Physiology (6 items) 74.9/3.76 ± 0.07 95.7/4.33 ± 0.06 94.5/4.39 ± 0.04 < 0.001/ 0.593/ < 0.001/ < 0.001/
< 0.001 0.138 < 0.001 < 0.001
Psychosocial (8 items) 60.1/3.50 ± 0.10 81.4/4.06 ± 0.12 87.7/4.24 ± 0.10 < 0.001/ 0.098/ < 0.001/ < 0.001/
< 0.001 0.002 < 0.001 < 0.001
Spirituality (8 items) 54.6/3.43 ± 0.22 89.2/4.30 ± 0.10 89.8/4.35 ± 0.05 < 0.001/ 0.855/ < 0.001/ < 0.001/
< 0.001 0.458 < 0.001 < 0.001
Knowledge (8 items) 62.5/3.51 ± 0.25 88.6/4.23 ± 0.14 89.7/4.32 ± 0.09 < 0.001/ 0.813/ < 0.001/ < 0.001/
< 0.001 0.332 < 0.001 < 0.001
Attitude (6 items) 65.1/3.60 ± 0.18 91.4/4.26 ± 0.14 91.9/4.34 ± 0.04 < 0.001/ 0.860/ < 0.001/ < 0.001/
< 0.001 0.282 < 0.001 < 0.001
Skill (8 items) 59.5/3.54 ± 0.15 85.3/4.18 ± 0.19 89.7/4.30 ± 0.13 < 0.001/ 0.344/ < 0.001/ < 0.001/
< 0.001 0.133 < 0.001 < 0.001
Equipment (3 items) 64.4/3.62 ± 0.38 89.7/4.26 ± 0.15 87.8/4.23 ± 0.17 0.110/ 0.869/ 0.062/ 0.078/
0.037 0.878 0.021 0.026
Overall (5 items) 65.0/3.67 ± 0.10 93.0/4.37 ± 0.10 94.2/4.29 ± 0.07 < 0.001/ 0.667/ < 0.001/ < 0.001/
< 0.001 0.306 < 0.001 < 0.001
Grand total (30 items) 62.9/3.57 ± 0.20 89.1/4.25 ± 0.15 90.7/4.31 ± 0.10 < 0.001/ 0.447/ < 0.001/ < 0.001/
< 0.001 0.114 < 0.001 < 0.001
*Data presented as percentage of families who answered “satisfied” and “strongly satisfied” (≥ 4 on a 5-point scale ranging from 1: strongly dissatisfied to
5: strongly satisfied) or mean ± standard deviation (5-point scale ranging from 1: strongly dissatisfied to 5: strongly satisfied); †c2 test for categorical data
and analysis of variance were used for comparing mean values of continuous variables between groups; ‡c2 test and post hoc comparison between 
hospice ward (HW) group and mixed group using the least significant difference (LSD) test; §c2 test and post hoc comparison between HW and 
general ward (GW) groups using the LSD test; c2 test and post hoc comparison between mixed and GW groups using the LSD test. GW = general ward;
HW = hospice ward.
Expenditure and family satisfaction with hospices
J Formos Med Assoc | 2009 • Vol 108 • No 10 801
of the differences between the three groups stud-
ied, and further work in this area is merited.
There are some limitations to our study. First,
the response rate in the family satisfaction ques-
tionnaire was low, which could reduce the appli-
cability of the findings. One possible explanation
for this lack of response might have been the in-
herently difficult timing of the questionnaire for
the family (at time of death and during the griev-
ing process). Second, the admission period of this
study only focused on the final admission before
death, and not on medical expenditure for the
entire terminal stage. Within the duration of the
final admission, however, average daily medical
expenditure was lowest in the HW group, regard-
less of length of stay. Third, the family satisfac-
tion questionnaire was assessed only for content
validity (not predictive, concurrent, construct, or
incremental validity) before being used in the
study. However, a previous study has demon-
strated that content validity is a reliable way to
design a questionnaire for use in clinical stud-
ies.16 Until further validation is completed on
this questionnaire, we rely solely on the opinion
of our expert panel to determine the ability of
this questionnaire to reflect the thinking of the
terminal patients’ families. Finally, although the
recall bias associated with questionnaire-based
research cannot be ruled out in this study, the
timing of questionnaire administration did not
differ between the groups and thus would not
have been expected to affect the study outcomes.
In summary, we demonstrated that hospice
care not only saved medical expenditure, but was
associated with greater family satisfaction than
was general care. The use of hospice care for ter-
minal cancer patients should be encouraged to
increase family satisfaction and reduce medical
expenditure in Taiwan and other countries.
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